These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24975222)

  • 21. Resveratrol suppresses cancer cell glucose uptake by targeting reactive oxygen species-mediated hypoxia-inducible factor-1α activation.
    Jung KH; Lee JH; Thien Quach CH; Paik JY; Oh H; Park JW; Lee EJ; Moon SH; Lee KH
    J Nucl Med; 2013 Dec; 54(12):2161-7. PubMed ID: 24221993
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Berberine Reverses Hypoxia-induced Chemoresistance in Breast Cancer through the Inhibition of AMPK- HIF-1α.
    Pan Y; Shao D; Zhao Y; Zhang F; Zheng X; Tan Y; He K; Li J; Chen L
    Int J Biol Sci; 2017; 13(6):794-803. PubMed ID: 28656004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxia-inducible factor 1alpha- mediated resistance to phenolic anticancer.
    Hyun JY; Chun YS; Kim TY; Kim HL; Kim MS; Park JW
    Chemotherapy; 2004 Jun; 50(3):119-26. PubMed ID: 15272226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways.
    Yan Y; Liu F; Han L; Zhao L; Chen J; Olopade OI; He M; Wei M
    J Exp Clin Cancer Res; 2018 Oct; 37(1):256. PubMed ID: 30340507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mad1 mediates hypoxia-induced doxorubicin resistance in colon cancer cells by inhibiting mitochondrial function.
    Cho K; Shin HW; Kim YI; Cho CH; Chun YS; Kim TY; Park JW
    Free Radic Biol Med; 2013 Jul; 60():201-10. PubMed ID: 23459071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asbestos induces doxorubicin resistance in MM98 mesothelioma cells via HIF-1alpha.
    Riganti C; Doublier S; Aldieri E; Orecchia S; Betta PG; Gazzano E; Ghigo D; Bosia A
    Eur Respir J; 2008 Aug; 32(2):443-51. PubMed ID: 18385176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor cells upregulate normoxic HIF-1α in response to doxorubicin.
    Cao Y; Eble JM; Moon E; Yuan H; Weitzel DH; Landon CD; Nien CY; Hanna G; Rich JN; Provenzale JM; Dewhirst MW
    Cancer Res; 2013 Oct; 73(20):6230-42. PubMed ID: 23959856
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Promoting Effect of Radiation on Glucose Metabolism in Breast Cancer Cells under the Treatment of Cobalt Chloride.
    Zhao CB; Shi L; Pu HH; Zhang QY
    Pathol Oncol Res; 2017 Jan; 23(1):47-53. PubMed ID: 27342248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gefitinib circumvents hypoxia-induced drug resistance by the modulation of HIF-1alpha.
    Rho JK; Choi YJ; Lee JK; Ryoo BY; Na II; Yang SH; Kim CH; Yoo YD; Lee JC
    Oncol Rep; 2009 Mar; 21(3):801-7. PubMed ID: 19212642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FBXO11 represses cellular response to hypoxia by destabilizing hypoxia-inducible factor-1α mRNA.
    Ju UI; Park JW; Park HS; Kim SJ; Chun YS
    Biochem Biophys Res Commun; 2015 Sep; 464(4):1008-1015. PubMed ID: 26187670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitoxantrone inhibits HIF-1α expression in a topoisomerase II-independent pathway.
    Toh YM; Li TK
    Clin Cancer Res; 2011 Aug; 17(15):5026-37. PubMed ID: 21653687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of HIF-1α inhibition in breast cancer cells prior to doxorubicin treatment under conditions of normoxia and hypoxia.
    Fourie C; du Plessis M; Mills J; Engelbrecht AM
    Exp Cell Res; 2022 Oct; 419(2):113334. PubMed ID: 36044939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of metformin and resveratrol in the prevention of hypoxia-inducible factor 1α accumulation and fibrosis in hypoxic adipose tissue.
    Li X; Li J; Wang L; Li A; Qiu Z; Qi LW; Kou J; Liu K; Liu B; Huang F
    Br J Pharmacol; 2016 Jun; 173(12):2001-15. PubMed ID: 27059094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sex differences in improved efficacy of doxorubicin chemotherapy in Cbr1+/- mice.
    Freeland MM; Angulo J; Davis AL; Flook AM; Garcia BL; King NA; Mangibin SK; Paul KM; Prosser ME; Sata N; Bentley JL; Olson LE
    Anticancer Drugs; 2012 Jul; 23(6):584-9. PubMed ID: 22343424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resveratrol Inhibits Hypoxia-Induced Vascular Endothelial Growth Factor Expression and Pathological Neovascularization.
    Lee CS; Choi EY; Lee SC; Koh HJ; Lee JH; Chung JH
    Yonsei Med J; 2015 Nov; 56(6):1678-85. PubMed ID: 26446654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoxia induced multidrug resistance of laryngeal cancer cells via hypoxia-inducible factor-1α.
    Li DW; Dong P; Wang F; Chen XW; Xu CZ; Zhou L
    Asian Pac J Cancer Prev; 2013; 14(8):4853-8. PubMed ID: 24083758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HS-1793, a resveratrol analogue, downregulates the expression of hypoxia-induced HIF-1 and VEGF and inhibits tumor growth of human breast cancer cells in a nude mouse xenograft model.
    Kim DH; Sung B; Kim JA; Kang YJ; Hwang SY; Hwang NL; Suh H; Choi YH; Im E; Chung HY; Kim ND
    Int J Oncol; 2017 Aug; 51(2):715-723. PubMed ID: 28656256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Confluence-dependent resistance to doxorubicin in human MDA-MB-231 breast carcinoma cells requires hypoxia-inducible factor-1 activity.
    Fang Y; Sullivan R; Graham CH
    Exp Cell Res; 2007 Mar; 313(5):867-77. PubMed ID: 17289019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CITED2 mediates the paradoxical responses of HIF-1alpha to proteasome inhibition.
    Shin DH; Li SH; Chun YS; Huang LE; Kim MS; Park JW
    Oncogene; 2008 Mar; 27(13):1939-44. PubMed ID: 17906695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIF-1α forms regulatory loop with YAP to coordinate hypoxia-induced adriamycin resistance in acute myeloid leukemia cells.
    Zhu B; Pan S; Liu J; Wang S; Ni Y; Xiao L; Wei Q; Peng Y; Ding Z; Zhao W
    Cell Biol Int; 2020 Feb; 44(2):456-466. PubMed ID: 31617641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.